Premium
Warfarin pharmacogenetics in the era of new oral anticoagulants
Author(s) -
Wright G.E.B.
Publication year - 2015
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12609
Subject(s) - edoxaban , warfarin , pharmacogenetics , medicine , randomized controlled trial , cyp2c9 , clinical trial , pharmacology , intensive care medicine , atrial fibrillation , rivaroxaban , genetics , genotype , biology , gene , cytochrome p450 , metabolism
Genetics and the clinical response to warfarin and edoxaban: findings from the randomized, double‐blind ENGAGE AF‐TIMI 48 trial Mega et al. (2015) Lancet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom